BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lamolle G, Marin M, Alvarez-Valin F. Silent mutations in the gene encoding the p53 protein are preferentially located in conserved amino acid positions and splicing enhancers. Mutat Res 2006;600:102-12. [PMID: 16650445 DOI: 10.1016/j.mrfmmm.2006.03.004] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 1.3] [Reference Citation Analysis]
Number Citing Articles
1 López I, P Oliveira L, Tucci P, Alvarez-Valín F, A Coudry R, Marín M. Different mutation profiles associated to P53 accumulation in colorectal cancer. Gene. 2012;499:81-87. [PMID: 22373952 DOI: 10.1016/j.gene.2012.02.011] [Cited by in Crossref: 34] [Cited by in F6Publishing: 34] [Article Influence: 3.4] [Reference Citation Analysis]
2 Marin M. Folding at the rhythm of the rare codon beat. Biotechnol J 2008;3:1047-57. [PMID: 18624343 DOI: 10.1002/biot.200800089] [Cited by in Crossref: 65] [Cited by in F6Publishing: 66] [Article Influence: 4.6] [Reference Citation Analysis]
3 Ahmadi S, Wade-Martins R. Familial Alzheimer's disease coding mutations reduce Presenilin-1 expression in a novel genomic locus reporter model. Neurobiol Aging 2014;35:443.e5-443.e16. [PMID: 24011544 DOI: 10.1016/j.neurobiolaging.2013.07.026] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
4 Scacchi R, Gambina G, Moretto G, Corbo RM. A mutation screening by DHPLC of PSEN1 and APP genes reveals no significant variation associated with the sporadic late-onset form of Alzheimer's disease. Neurosci Lett 2007;418:282-5. [PMID: 17412506 DOI: 10.1016/j.neulet.2007.03.035] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
5 Kouidou S, Malousi A, Maglaveras N. Li-Fraumeni and Li-Fraumeni-like syndrome mutations in p53 are associated with exonic methylation and splicing regulatory elements: LF/LFL SYNDROME MUTATIONS IN p53. Mol Carcinog 2009;48:895-902. [DOI: 10.1002/mc.20537] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
6 Hrstka R, Coates PJ, Vojtesek B. Polymorphisms in p53 and the p53 pathway: roles in cancer susceptibility and response to treatment. J Cell Mol Med. 2009;13:440-453. [PMID: 19379143 DOI: 10.1111/j.1582-4934.2008.00634.x] [Cited by in Crossref: 41] [Cited by in F6Publishing: 36] [Article Influence: 3.2] [Reference Citation Analysis]
7 Supek F, Miñana B, Valcárcel J, Gabaldón T, Lehner B. Synonymous Mutations Frequently Act as Driver Mutations in Human Cancers. Cell 2014;156:1324-35. [DOI: 10.1016/j.cell.2014.01.051] [Cited by in Crossref: 340] [Cited by in F6Publishing: 302] [Article Influence: 42.5] [Reference Citation Analysis]
8 Gomes CC, Diniz MG, Orsine LA, Duarte AP, Fonseca-Silva T, Conn BI, De Marco L, Pereira CM, Gomez RS. Assessment of TP53 mutations in benign and malignant salivary gland neoplasms. PLoS One 2012;7:e41261. [PMID: 22829934 DOI: 10.1371/journal.pone.0041261] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 2.0] [Reference Citation Analysis]
9 Ghigna C, Valacca C, Biamonti G. Alternative splicing and tumor progression. Curr Genomics. 2008;9:556-570. [PMID: 19516963 DOI: 10.2174/138920208786847971] [Cited by in Crossref: 121] [Cited by in F6Publishing: 119] [Article Influence: 11.0] [Reference Citation Analysis]
10 Fåhraeus R, Marin M, Olivares-Illana V. Whisper mutations: cryptic messages within the genetic code. Oncogene 2016;35:3753-9. [PMID: 26657150 DOI: 10.1038/onc.2015.454] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 2.4] [Reference Citation Analysis]
11 Bhagavatula G, Rich MS, Young DL, Marin M, Fields S. A Massively Parallel Fluorescence Assay to Characterize the Effects of Synonymous Mutations on TP53 Expression. Mol Cancer Res 2017;15:1301-7. [PMID: 28652265 DOI: 10.1158/1541-7786.MCR-17-0245] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.4] [Reference Citation Analysis]
12 Kriangkum J, Warkentin A, Belch AR, Pilarski LM. Alteration of introns in a hyaluronan synthase 1 (HAS1) minigene convert Pre-mRNA [corrected] splicing to the aberrant pattern in multiple myeloma (MM): MM patients harbor similar changes. PLoS One 2013;8:e53469. [PMID: 23301075 DOI: 10.1371/journal.pone.0053469] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
13 Ercan C, van Diest PJ, van der Ende B, Hinrichs J, Bult P, Buerger H, van der Wall E, Derksen PW. p53 mutations in classic and pleomorphic invasive lobular carcinoma of the breast. Cell Oncol (Dordr) 2012;35:111-8. [PMID: 22354696 DOI: 10.1007/s13402-012-0071-y] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.4] [Reference Citation Analysis]
14 Robles AI, Jen J, Harris CC. Clinical Outcomes of TP53 Mutations in Cancers. Cold Spring Harb Perspect Med 2016;6:a026294. [PMID: 27449973 DOI: 10.1101/cshperspect.a026294] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 4.5] [Reference Citation Analysis]
15 Marín M, Fernández-Calero T, Ehrlich R. Protein folding and tRNA biology. Biophys Rev 2017;9:573-88. [PMID: 28944442 DOI: 10.1007/s12551-017-0322-2] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
16 Adamia S, Reichert AA, Kuppusamy H, Kriangkum J, Ghosh A, Hodges JJ, Pilarski PM, Treon SP, Mant MJ, Reiman T. Inherited and acquired variations in the hyaluronan synthase 1 (HAS1) gene may contribute to disease progression in multiple myeloma and Waldenstrom macroglobulinemia. Blood. 2008;112:5111-5121. [PMID: 18815290 DOI: 10.1182/blood-2008-02-141770] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 1.7] [Reference Citation Analysis]
17 Fernández-Calero T, Astrada S, Alberti A, Horjales S, Arnal JF, Rovira C, Bollati-Fogolín M, Flouriot G, Marin M. The transcriptional activities and cellular localization of the human estrogen receptor alpha are affected by the synonymous Ala87 mutation. J Steroid Biochem Mol Biol 2014;143:99-104. [PMID: 24607813 DOI: 10.1016/j.jsbmb.2014.02.016] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
18 Karambataki M, Malousi A, Maglaveras N, Kouidou S. Synonymous polymorphisms at splicing regulatory sites are associated with CpGs in neurodegenerative disease-related genes. Neuromolecular Med 2010;12:260-9. [PMID: 20077034 DOI: 10.1007/s12017-009-8111-0] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
19 Kolesárová V, Šiviková K, Holečková B, Dianovský J. A comparative FISH mapping of LCA5L gene in cattle, sheep, and goats. Anim Biotechnol 2015;26:37-9. [PMID: 25153453 DOI: 10.1080/10495398.2013.877917] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
20 Tang JY, Lee JC, Hou MF, Wang CL, Chen CC, Huang HW, Chang HW. Alternative splicing for diseases, cancers, drugs, and databases. ScientificWorldJournal 2013;2013:703568. [PMID: 23766705 DOI: 10.1155/2013/703568] [Cited by in Crossref: 17] [Cited by in F6Publishing: 22] [Article Influence: 1.9] [Reference Citation Analysis]
21 Latorre E, Harries LW. Splicing regulatory factors, ageing and age-related disease. Ageing Research Reviews 2017;36:165-70. [DOI: 10.1016/j.arr.2017.04.004] [Cited by in Crossref: 28] [Cited by in F6Publishing: 23] [Article Influence: 5.6] [Reference Citation Analysis]